Skip to main content
Evidence-Based Mental Health logoLink to Evidence-Based Mental Health
. 2022 Jul 7;25(3):110–116. doi: 10.1136/ebmental-2022-300460

The impact of mindfulness training in early adolescence on affective executive control, and on later mental health during the COVID-19 pandemic: a randomised controlled trial

Darren Dunning 1, S Ahmed 2, L Foulkes 2, C Griffin 2, K Griffiths 1, J T Leung 2, J Parker 1, Blanca Piera Pi-Sunyer 2, A Sakhardande 2, M Bennett 1, C Haag 1, Jesus Montero-Marin 3,4, D Packman 5, Maris Vainre 1, P Watson 1; The MYRIAD Team, Willem Kuyken 4, J Mark G Williams 4, Obioha C Ukoumunne 6, Sarah-Jayne Blakemore 2,7, Tim Dalgleish 1,
PMCID: PMC9340025  PMID: 35820991

Abstract

Background

Previous research suggests that mindfulness training (MT) appears effective at improving mental health in young people. MT is proposed to work through improving executive control in affectively laden contexts. However, it is unclear whether MT improves such control in young people. MT appears to mitigate mental health difficulties during periods of stress, but any mitigating effects against COVID-related difficulties remain unexamined.

Objective

To evaluate whether MT (intervention) versus psychoeducation (Psy-Ed; control), implemented in after-school classes: (1) Improves affective executive control; and/or (2) Mitigates negative mental health impacts from the COVID-19 pandemic.

Methods

A parallel randomised controlled trial (RCT) was conducted (Registration: https://osf.io/d6y9q/; Funding: Wellcome (WT104908/Z/14/Z, WT107496/Z/15/Z)). 460 students aged 11-16 years were recruited and randomised 1:1 to either MT (N=235) or Psy-Ed (N=225) and assessed preintervention and postintervention on experimental tasks and self-report inventories of affective executive control. The RCT was then extended to evaluate protective functions of MT on mental health assessed after the first UK COVID-19 lockdown.

Findings

Results provided no evidence that the version of MT used here improved affective executive control after training or mitigated negative consequences on mental health of the COVID-19 pandemic relative to Psy-Ed. No adverse events were reported.

Conclusions

There is no evidence that MT improves affective control or downstream mental health of young people during stressful periods.

Clinical implications

We need to identify interventions that can enhance affective control and thereby young people’s mental health.

Keywords: child & adolescent psychiatry


What is already known on this topic

  • A key mechanism of action of mindfulness-based interventions in delivering mental health benefits is hypothesised to be enhancing executive control in affectively or socially charged contexts.

  • Experimental research to date has tended to focus on executive control as a cold cognitive capacity rather than on its selective application in socially or affectively charged contexts.

What this study adds

  • Using an adequately powered RCT with experienced teachers and good engagement from volunteer student participants we found no support for the hypothesis that a widely used mindfulness-based intervention for young people (.b) compared with an active psychoeducation control condition (Psy-Ed), would deliver superior changes in affective executive control.

  • An opportunistic extension of the trial into the period of the COVID-19 pandemic found no support for .b offering superior protection against worsening mental health relative to Psy-Ed.

How this study might affect research, practice or policy

  • The next generation of research needs to consider what works, for whom, in addition to how, as well as considering key contextual and implementation factors.

Introduction

Mindfulness training (MT) involves systematic practice in focusing attention in a sustained and intentional way.1 MT has been shown to prevent and/or improve mental health problems in clinical and non-clinical adult samples, and MT in young people appears promising as a preventive intervention.2 3 However, less is known about the mechanisms that drive these MT-related improvements in mental health.4 Understanding the mechanisms of MT is essential as it allows further refinement of MT to target those mechanisms, and can inform other interventions that also target the same mechanisms.

A compelling proposal is that positive effects of MT on mental health are mediated by improvements in executive control in affective contexts; specifically, improvements in the ability to allocate mental resources in the service of pertinent goals in the face of affectively salient distraction.4 5 Such affective executive control is typically measured using experimental cognitive tasks that assay executive control separately in affectively laden and neutral contexts. The degree to which affective, relative to neutral, contexts lead to a performance decrement is the index of affective executive control. Importantly, affective executive control appears to improve following systematic training6 7 and to be compromised in individuals suffering from mental health difficulties, including in younger samples.8

Although several studies have used experimental tasks to measure changes in diverse executive skills following MT, they tend to have used emotionally neutral tasks that lack the requisite affective condition for indexing performance in affective contexts. Results are mixed with studies reporting either gains or no effects following MT in skills including sustained attention, selective attention/inhibition, and working memory.3

Objective

Here, we report a randomised controlled trial (RCT) to evaluate whether MT improves performance on experimental and self-report measures of affective executive control in young people aged 11–16 years. The RCT compared MT to a psychoeducation control condition (Psy-Ed), comparable in length and complexity to MT. Importantly, a Psy-Ed control (Student Success Skills (SSS)9) was chosen that should deliver comparable postintervention effects to MT on mental health outcomes.9 This allows us to disentangle any differential effects of MT versus Psy-Ed on affective executive control from effects on mental health.

Our hypothesis was that MT, relative to Psy-Ed, would deliver greater improvements in affective executive control. If this hypothesis was supported, it would allow us to test a follow-on interactive mediation hypothesis10 that, in contrast to the Psy-Ed arm, any changes in mental health outcomes in the MT trial arm would be differentially driven by improvements in this key mechanism of affective executive control.

Following completion of the RCT, the onset of the COVID-19 global pandemic led to significant social changes in the UK for young people, including a national lockdown involving school closures. We know from trials in older students that the key skills taught during MT can protect against deterioration in mental health during periods of stress, even if there are no apparent MT-related mental health benefits prior to the onset of stress.11 Due to the incumbent stress and potential negative impacts on mental health of the COVID-related pandemic,12 we decided to extend the RCT to include an additional wave of data collection following the first UK COVID-19 lockdown in summer 2020. We hypothesised that MT, relative to Psy-Ed, delivered prior to the pandemic, would mitigate the subsequent development of pandemic-related mental health difficulties.

Methods

The trial is reported in accordance with CONSORT guidelines. The full study design and procedures, including the COVID-related extension, are presented in the trial protocol.13

Study design and participants

A superiority randomised controlled, parallel-group mechanisms trial—as part of the broader My Resilience in Adolescence (MYRIAD) programme of work focused on evaluating and understanding MT in adolescence—compared MT (intervention) with Psy-Ed (control) to test the hypothesis that MT would have a superior effect on measures of affective executive control at postintervention. Following the onset of the COVID-19 pandemic, we extended the trial to include an additional mid-pandemic assessment to test the hypothesis that MT is superior to Psy-Ed in mitigating symptoms of mental ill health and promoting well-being following the onset of the pandemic.

There were three key assessment points: Time 1 (T1, January 2017 to March 2019): prerandomisation baseline—a face-to-face assessment 1–2 weeks prior to the start of the interventions; Time 2 (T2, March 2017 to May 2019): Postintervention—a face-to-face assessment and the primary end point for affective executive control outcomes; Time 4 (T4, June–July 2020): 20–44 months after the interventions finished, following the first UK lockdown during the COVID-19 pandemic—an online assessment and the primary end point for the mental health outcomes. The reason for the large time window for this T4 assessment was that all participants were assessed at the same time during July 2020, whereas the original trial was spread over a 26-month recruitment period. An additional online assessment of mental health outcomes (Time 3, T3: June 2017 to August 2019) was completed 3 months after the interventions to enable putative analyses of longer-term mediating effects of changes in affective executive control on changes in mental health.

Participant flow is described in the Consolidated Standards of Reporting Trials (CONSORT) diagram (figure 1). Twelve secondary schools from London and Cambridgeshire were recruited. Participants were students aged 11–16 years. All students had the opportunity to take part unless they had a self-reported: (1) Learning difficulty or neurodevelopmental or neurological disorder; (2) Mood disorder currently in episode. Eligible students were asked to return a signed parental consent form, and places were offered on a first-come-first-served basis until our target sample size was achieved. Assent was obtained from all participants. As this was a mechanisms trial, we sought to maximise the probability that students received a complete dose of the interventions. Participants were therefore paid up to £100 for their contribution, based on session attendance and homework completion, to maximise engagement. See online supplemental A for the payment breakdown, and additional information on school recruitment, and the data collection procedure.

Figure 1.

Figure 1

CONSORT flow chart for trial. MT, mindfulness training.

Supplementary data

ebmental-2022-300460supp001.pdf (499.8KB, pdf)

Randomisation and allocation concealment

After consent and assent forms were received, participants within a school were randomly assigned in a 1:1 ratio to MT or Psy-Ed following the Baseline (T1) assessment. Randomisation, with no stratification, was conducted by a statistician (PW), independent of the research team, in blocks of 10 participants with randomisation within each block applied using a computerised random number generator. Due to the nature of MT and Psy-Ed, participants and teachers were not blind to treatment allocation. Researchers collecting data at the face-to-face testing sessions were blind to intervention allocation.

Interventions

MT and Psy-Ed are described fully in online supplemental B, including adjustments to each intervention to compile 8-week programmes, and information about the training of intervention teachers. Information on assessment of teacher fidelity and student adherence is presented in online supplemental C.

Mindfulness training

The MT programme aimed to teach mindfulness skills1 that support young people’s resilience, using a combination of class discussion and mindfulness practice. MT used here was an adapted version of .b (dot-be), a 10-week mindfulness course for 11–18-year-old participants, developed by the Mindfulness in Schools Project.14 We selected .b due to the encouraging data on its efficacy on measures of mental ill health and well-being.15 The adjusted .b curriculum comprised eight 45 min, weekly MT sessions delivered face-to-face in small groups (10–13 participants), at the students’ school. Participants are asked to complete homework between sessions.

Psy-Ed curriculum

Psy-Ed was an adapted version of Student Success Skills9 an 8-week course designed to teach cognitive, social and self-management skills. Session length, format, delivery and homework requirements were comparable to MT.

Outcome measures

All measures are described in detail in online supplemental D. The timetable for their administration is presented in online supplemental table S1.

Affective executive control

To evaluate the hypothesised mechanism of affective executive control we administered three computer-administered experimental tasks and three questionnaires at baseline (T1) and postintervention (T2).

Affective working memory capacity

This complex span task measures the influence of affective contexts on working memory capacity.7 Participants are required to remember lists of neutral words, while simultaneously counting how many distracting shapes appear briefly on the screen. Task valence is manipulated via a background image that is either emotionally neutral or emotionally negative in content. Affective executive control is quantified as the proportion of words correctly recalled in the neutral condition minus the proportion correctly recalled in the negative condition.

Affective Stroop

This task measures the inhibitory component of affective executive control.16 Participants are presented with series of faces with either happy, neutral or sad expressions. A sad or happy word is superimposed over each face such that the resulting face-word pairs can be either congruent (matched in valence; eg, sad facial expression with a sad word), neutral (where the facial expression is pixelated out) or incongruent. Participants are required to categorise the words as ‘happy’ or ‘sad’ as quickly and accurately as possible, while trying to ignore the facial expression. Affective executive control is quantified as the reaction time (RT) to respond in the incongruent condition minus the RT for the congruent condition.

Affective sustained attention to response task (aSART)

This measures sustained attention in the face of affective distraction. Participants are presented with a stream of 540 single digits, one at a time. They are required to press a button as fast as possible for every digit unless it is a ‘3’ (the target) when they must withhold the button press.17 The digits are presented against a soundtrack that is either emotionally neutral or emotionally negative. The two indices of affective executive control are the number of commission errors (incorrectly pressing the button when presented with the target) and the RT variance for correct responses, with performance in the neutral condition subtracted from performance in the negative condition.

Questionnaires

Participants also completed: the Behaviour Rating Inventory of Executive Function (BRIEF18) as a self-report measure of executive control; the Child-Adolescent Mindfulness Measure19 to assess mindfulness skills; and the Difficulties in Emotion Regulation Scale (DERS20) to assess emotion regulation problems.

Mental health outcomes

We used three primary mental health outcomes in line with the MYRIAD pragmatic trial:21 symptoms of depression (Center for Epidemiological Studies Depression Scale22); social, emotional and behavioural functioning (Strengths and Difficulties Questionnaire Total score, SDQ-Total23); and well-being (Warwick-Edinburgh Mental Well-being Scale24).

We included a range of secondary mental health outcomes: the subscales of the SDQ; anxiety (total score and subscales from the Revised Child Anxiety and Depression Scale25) and rumination (Ruminative Response Scale26).

Statistical analysis

The target sample size of 450 students (225 students per trial arm) for the mechanisms RCT was calculated to detect a difference of 0.3 SD units (effect size) on any given affective control outcome measure, with 80% power, at an uncorrected 5% (two-sided) level of significance, assuming 20% attrition at postintervention (T2).

Participant characteristics were summarised using means and SDs for continuous variables and numbers and percentages for categorical variables. Outcomes were compared between trial arms using the intention-to-treat principle. If participants missed a subset of >20% of items for a given measure the outcome was counted as missing. Missing outcome data (assumed to be missing at random) were subject to multiple imputation using the ‘pan’ package in R27 (online supplemental E). Sensitivity analyses using complete case data were also undertaken for each outcome. Outcomes were compared between trial arms using mixed-effects (‘multilevel’) linear regression models, specifying a random intercept for school, adjusting for student gender and baseline (T1) score on the outcome.

We also explored the moderating effects of age and gender on the relationship between intervention received and our primary mechanisms outcomes at postintervention. Outcome analyses used the ‘mi’ suite of commands in Stata V.16.1.

Planned analyses of the putative mediating effect of affective executive control on the relationship between intervention received and mental health outcomes were dependent on robust effects of MT versus Psy-Ed on affective executive control.10 For the mediation analysis plan, see online supplemental F.

Results

Table 1 shows descriptive statistics for the MT and Psy-Ed groups at baseline (T1) on the primary affective executive control and mental health outcomes. For secondary mental health outcomes and additional affective executive control metrics at baseline, see online supplemental table S2 and S3, respectively.

Table 1.

Baseline (T1) characteristics by trial arm status

MT N=235 Psy-Ed N=225
N %/mean (SD) N %/mean (SD)
Location
 London 168 71.5% 160 70.8%
 Cambridge 67 28.5% 65 28.8%
Female 155 66.0% 151 67.1%
Age 235 13.8 (1.3) 225 13.9 (1.4)
IQ 221 110.6 (19.0) 218 109.5 (16.0)
CES-D 232 16.3 (9.9) 221 16.6 (10.3)
SDQ-Total 219 12.4 (5.7) 208 13.1 (5.6)
WEMWBS 232 47.1 (10.1) 222 47.2 (9.3)
CAMM-Total 233 25.2 (8.0) 221 24.1 (7.9)
BRIEF-Total 212 133.3 (24.6) 194 136.4 (24.4)
DERS-Total 224 85.4 (23.2) 217 88.3 (26.1)
aSART-C 193 0.5 (3.7) 191 0.2 (4.0)
aSART-RTV 193 0.01 (0.1) 192 0.01 (0.1)
aSTROOP 203 63.4 (93.2) 195 61.8 (102.4)
aWMC 219 0.02 (0.2) 205 0.03 (0.2)

aSART-C was computed as the number of errors in the negative condition minus the number in the neutral condition. aSART-C was reliably different to zero (directional 1-sample t-test) at baseline, t=1.79, p=.039. aSART-RTV was computed as RTV in negative condition minus the RTV in the neutral condition. aSART-RTV was reliably different to zero at baseline, t=2.89, p=.004. aStroop was computed as mean reaction time in the incongruent trials minus mean reaction time in the congruent trials. aStroop was reliably different to zero at baseline, t=12.78, p<.0001. aWMC was computed as the proportion of correctly remembered words in the neutral condition minus the proportion remembered in the negative condition. aWMC was reliably different to zero at baseline, t=3.06, p=.002.

aSART-C, Affective Sustained Attention to Response Task Commission error; aSART-RTV, Affective Sustained Attention to Response Task Reaction Time Variance; aStroop, Affective Stroop performance; aWMC, Affective Working Memory Capacity; BRIEF-Total, Behaviour Rating Inventory of Executive Function Version 2 Global Composite Score; CAMM-Total, Child and Adolescent Mindfulness Measure Total Score; CES-D, Center for Epidemiological Studies Depression Scale; DERS-Total, Difficulties with Emotion Regulation Scale Total Score; IQ, score on the Cattell Culture Fair Test29 ; MT, Mindfulness Training; Psy-Ed, psychoeducation training; SDQ-Total, Strengths and Difficulties Questionnaire Total Score; WEMWBS, Warwick-Edinburgh Mental Well-Being Scale.

At baseline, the three experimental tasks produced reliable decrements in performance in affective conditions relative to neutral conditions testifying to their validity as indices of affective executive control (table 1). There were also the expected relationships between underlying (non-affective) task performance (indexed by performance in the neutral task conditions only) and age and IQ, with performance being better with older age and higher IQ (online supplemental table S4). Finally, scores on several affective executive control measures were lower at baseline in individuals with higher levels of mental health difficulties. These relationships were stronger and more consistent for the self-report measures than for the tasks (online supplemental table S4).

Of students recruited to the trial, 87.2% (86.8% in MT; 87.5% in Psy-Ed) were retained at the primary postintervention end point (T2) for affective executive control outcomes. Students retained at T2 were younger, and less likely to be female or from a London school, relative to those lost to follow-up (online supplemental table S5). Of the recruited students, 45% (45.1% in MT; 44.8% in Psy-Ed) were retained at the mid-pandemic assessment (T4), the primary end point for the mid-pandemic mental health outcomes. Given that this T4 assessment was an unplanned trial extension, these lower retention rates are perhaps unsurprising. Students retained at T4 had a lower proportion from London schools relative to those lost to follow-up (online supplemental table S6).

Intervention dose, quality and fidelity

The two interventions were delivered as planned. Students received an average of 6.4 (SD=2.5) sessions of MT and 6.4 (SD=2.3) of Psy-Ed, out of a possible 8. Homework was scored as completed if students self-reported watching the homework video and carrying out the related exercises for that week, and also reported some daily practice of exercises or techniques from the previous lesson. Students reported completing an average of 5.1 (SD=2.3) weeks of homework assignments for MT and 4.5 (SD=2.3) for Psy-Ed, out of a possible 7. Remunerating students for homework completion appeared to enhance engagement when compared with our larger trial where homework was not remunerated and where students reported practising on average much less.21 On average, teachers were rated as delivering the intervention with high fidelity (MT=95.4% curriculum adherence; Psy-Ed=94.5%).

Trial outcomes

Affective executive control outcomes

The primary affective executive control outcomes at postintervention (T2) are reported in table 2. There was no evidence of a difference between arms on any outcome. The conclusions of the sensitivity analyses using complete cases were robust to those of these primary analyses. There was no evidence of any moderating effects of age and gender on the relationship between intervention received and these affective control outcomes at postintervention (online supplemental table S7). For descriptive data and outcomes for the remaining experimental task metrics and the BRIEF and DERS subscales at T2, see online supplemental table S8. There was no evidence of a difference between arms on any of these additional variables. Because there was no support for an effect of intervention arm on any affective control outcomes, follow-up mediation analyses that presuppose such effects were not indicated,10 despite some evidence that changes in affective executive control (on the DERS, the BRIEF and the affective sustained attention to response task) related to changes in mental health across the intervention period (online supplemental table S9).

Table 2.

Primary affective executive control outcomes at postintervention (T2)

MT Psy-Ed Unadjusted (I–C) Adjusted (I-C)
N Mean (SD) N Mean (SD) Mean diff. Mean diff. 95% CI P value
CAMM-Total 204 24.8 (7.8) 195 24.2 (8.2) −0.08 −0.1 −1.7 to 1.4 0.86
BRIEF-Total 187 133.3 (25.4) 175 136.9 (26.8) −4.4 −2.5 −6.9 to 1.9 0.27
DERS-Total 200 85.8 (23.4) 194 87.1 (25.8) 0.8 1.0 −3.8 to 5.7 0.69
aSART-C 168 −0.1 (4.0) 157 0.2 (4.1) −0.3 −0.3 −1.4 to 0.7 0.52
aSART-RTV 168 −0.005 (0.1) 158 −0.007 (0.1) −0.004 −0.01 −0.1 to 0.1 0.90
aSTROOP 172 38.1 (72.0) 162 54.3 (111.5) −18.9 −20.2 −41.7 to 1.4 0.07
aWMC 148 −0.02 (0.1) 156 −0.02 (0.1) 0.02 0.02 −0.1 to 0.1 0.61

Data presented are complete cases. Inferential statistics are on the full imputed data set (n=460). aSART-C was computed as the number of errors in the negative condition minus the number in the neutral condition. aSART-RTV was computed as RTV in negative condition minus the RTV in the neutral condition. aStroop was computed as mean reaction time in the incongruent trials minus mean reaction time in the congruent trials. aWMC was computed as the proportion of correctly remembered words in the neutral condition minus the proportion remembered in the negative condition.

aSART-C, Affective Sustained Attention to Response Task Commission; aSART-RTV, Affective Sustained Attention to Response Task Reaction Time Variance; aStroop, Affective Stroop Performance; aWMC, Affective Working Memory Capacity; BRIEF-Total, Behaviour Rating Inventory of Executive Function version 2 Global Composite Score; C, Control (Psy-Ed); CAMM-Total, Child and Adolescent Mindfulness Measure Total Score; DERS-Total, Difficulties with Emotion Regulation Scale Total Score; I, Intervention (MT); MT, mindfulness training; Psy-Ed, psychoeducation training.

Mental health outcomes

The primary mental health outcomes are reported at the relevant end point (T4) to assess mid-pandemic mental health in table 3, along with outcomes at postintervention (T2). Secondary mental health outcomes are in online supplemental table S10. For completeness, the additional 3-month assessment (T3) mental health outcomes are in online supplemental table S11.

Table 3.

Primary mental health outcomes at the mid-pandemic primary end point (T4) and at postintervention (T2)

Time point MT Psy-Ed Unadjusted (I–C) Adjusted (I-C)
N Mean (SD) N Mean (SD) Mean diff. Mean diff. 95% CI P value
CES-D Postintervention 204 15.9 (9.8) 196 16.9 (10.9) −1.2 −1.1 −3.1 to 0.9 0.27
Mid-pandemic 106 20.8 (11.4) 101 21.2 (12.7) −0.1 −0.09 −2.9 to 2.8 0.95
SDQ-Total Postintervention 203 11.8 (5.7) 196 13.0 (5.9) −0.8 −0.8 −1.9 to 0.2 0.13
Mid-pandemic 104 13.3 (4.9) 101 13.3 (6.0) 0.8 0.8 −0.7 to 2.4 0.28
WEMWBS Postintervention 203 48.0 (9.8) 196 47.7 (10.1) 1.0 0.9 −0.9 to 2.7 0.34
Mid-pandemic 106 44.6 (8.9) 101 45.2 (11.2) −0.002 −0.08 −2.6 to 2.4 0.95

Data presented are complete cases. Inferential statistics are on the full imputed data set (n=460).

C, Control (Psy-Ed); CES-D, Center for Epidemiological Studies Depression Scale; I, Intervention (MT); MT, mindfulness training; Psy-Ed, psychoeducation training; SDQ-Total, Strengths and Difficulties Questionnaire Total Score; WEMWBS, Warwick-Edinburgh Mental Well-Being Scale.

Student mental health across all outcomes was worse at mid-pandemic (T4), relative to the prepandemic, postintervention (T2) assessment (table 3; online supplemental table S10). However, there was no evidence of a difference between arms at mid-pandemic (T4) for any primary or secondary mental health outcome, with the exception of the secondary outcome of the Conduct Disorder subscale of the SDQ for which scores were lower (indicative of better mental health) in the Psy-Ed arm. The conclusions of the sensitivity analyses of complete cases were robust to those of the primary analyses. The pattern of findings was similar at postintervention (T2) with no significant differences between arms on any mental health outcome (table 3; online supplemental table S10).

Adverse events

For the duration of the interventions, students were advised that they could report any problems or unwanted effects in relation to either intervention to their external intervention teacher or to their internal classroom teacher. We also asked students at the end of the intervention about their experiences, including any unwanted effects. No adverse events were reported.

Discussion

This randomised controlled mechanisms trial evaluated the impact of a widely used MT programme, relative to a Psy-Ed control intervention, in early adolescence on experimental-tasks and self-report measures of the key proposed mechanism-of-action of MT—affective executive control. There was no evidence for a superior impact of MT, relative to Psy-Ed, on any measure of affective executive control. The mechanisms trial was completed just prior to the onset of the worldwide COVID-19 pandemic. We therefore took the opportunity to extend the trial to a mid-pandemic assessment following the first UK national lockdown in summer 2020 to evaluate the hypothesis that MT, relative to Psy-Ed, would mitigate against detrimental effects of the pandemic on mental health. We found no evidence to support this hypothesis.

It is always difficult to interpret null findings and conclusions must therefore be tentative. There are a number of possible explanations for the null findings with respect to affective executive control. In the absence of a no intervention or passive control condition it is not possible to draw definitive conclusions on which of these explanations is most valid. First, it may be that either MT does not have a differential effect on this proposed mechanism of action, or that both MT and Psy-Ed affect this mechanism, or that the effect is delayed beyond the postintervention time point, or that it affects subgroups differently.28 Second, it may be that the version of MT used here—.b—is actually benign and does not deliver sufficient training in key mindfulness skills to impact our outcomes. We selected .b due to its encouraging results in our pilot trial.15 The intervention was also delivered with high fidelity by experienced external teachers, and we ensured good engagement from participants through financial compensation. However, in our subsequent large-scale pragmatic trial21 we found no support for .b on any mental health outcome measure. Finally, it may be that our affective control outcomes were insensitive measures of control. This seems unlikely to be uniformly true as they comprised a broad set of widely used measures, both experimental and self-report, including a measure of mindfulness skills overlapping closely in content with the content of the .b curriculum.

In terms of the mid-pandemic mental health outcomes, it may be that both MT and Psy-Ed are efficacious or that neither is efficacious. Alternatively, it may be that MT offers protection for different outcomes than those used here, or only when the intervention is delivered closer in time to the stressor.

The study has a number of noteworthy strengths. The trial was adequately powered to address its primary mechanisms question. MT was delivered with good fidelity by experienced teachers. There was good engagement from students and we had good retention at the primary mechanisms end point (87%). We used a mix and range of self-report and experimental measures of affective executive control and a comprehensive set of mental health outcomes.

The study also had a number of limitations. Students and teachers were necessarily not blind to treatment allocation. We did not include a no intervention or passive control condition limiting the conclusions that can be drawn from the present pattern of null findings. We did not include a follow-up assessment for the affective executive control measures. Finally, for the unscheduled COVID-related mental health trial extension, retention rates were perhaps unsurprisingly low, and there was a wide range of follow-up duration from the trial baseline.

Conclusions

In a rigorous, randomised controlled mechanisms trial we found no support for our hypothesis that MT would have a greater postintervention impact on affective executive control relative to Psy-Ed. In a trial extension, we found no support for MT conferring protection against deterioration in mental health following the onset of the COVID-19 pandemic relative to Psy-Ed. It may be that MT has no impact on affective executive control or stressor-related mental health, that both MT and Psy-Ed have a comparable impact, or that the version of MT deployed here—.b—was benign. In the absence of additional control conditions definitive conclusions are not possible.

Footnotes

Twitter: @MarisVainre

Collaborators: The MYRIAD Team Group Authorship comprises Katie Fletcher, Lucy Konstantina Komninidou, Rachel Knight, Suzannah Laws, Elise Sellars, Lucy Warriner and Brian Wainman. These individuals have worked across the MYRIAD strategic award ‘Promoting Mental Health and Building Resilience in Adolescence: Investigating Mindfulness and Attentional Control’, they are acknowledged as group authors for their contributions to the project in accordance with the MYRIAD Dissemination Protocol. The authors would also like to acknowledge the wider MYRIAD Team for their contribution to this work: The additional MYRIAD research team at the University of Oxford: Ruth Baer, Daniel Brett, Eleanor-Rose Farley, Triona Casey, Nicola Dalrymple, Katherine De Wilde, Katie Fletcher, Jennifer Harper, Verena Hinze, Nils Kapplemann, Maria Kempnich, Konstantina Komnindou, Suzannah Laws, Liz Lord, Emma Medlicott, Lucy Palmer, Ariane Petit, Alice Phillips, Isobel Pryor-Nitsch, Lucy Radley, Anam Raja, Elsie Sellars, Jem Shackleford, Anna Sonley, Laura Taylor, Alice Tickell, and Lucy Warriner.Additional MYRIAD Co-Investigators: Sarah Byford (KCL), Mark Greenberg (Penn State), Tamsin Ford (Cambridge), Susan Gathercole (MRC CBU), Russell Viner (UCH), Phil Zelazo (Minnesota) Additional Cambridge, UCL, KCL and Exeter research team: Rachel Knight, Blanca Piera Pi-Sunyer, Kirsten Thomas, Susan Ball, Ben Jones, Poushali Ganguli.We are grateful to the members of the Scientific Advisory Board for the programme as a whole (Nick Allen, Susan Bogels, Pim Cuijpers, Celene Domitrovich, Uta Frith (Chair), Terrie Moffitt, Vikram Patel).

Contributors: WK, JMGW, TD, OCU, TF and S-JB were responsible for the original proposal and securing funding for the trial. TD, DD and OCU have verified the underlying data. TD and S-JB had overall responsibility for the management of the study and are study guarantors. Authors are members of the study team who made a major scientific, pragmatic and/or strategic contribution. All authors read and approved the final manuscript.

Funding: This research was funded by Wellcome (WT104908/Z/14/Z and WT107496/Z/15/Z) and supported by the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre. The funders had no role in study design, data collection, analysis or interpretation nor in writing the paper. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. Obi Ukoumunne was supported by the National Institute for Health Research (NIHR) Applied Research Collaboration (ARC) South West Peninsula. JM-M has a “Miguel Servet” research contract from the ISCIII (CP21/00080). The views expressed are those of the author(s) and not necessarily those of the funders.

Competing interests: WK is the Director of the Oxford Mindfulness Centre and receives royalties for several books on mindfulness. JMGW is former Director of the Oxford Mindfulness Centre and receives royalties for several books on mindfulness.

Provenance and peer review: Not commissioned; externally peer reviewed.

Supplemental material: This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

Contributor Information

Collaborators: The MYRIAD Team Group, Ruth Baer, Daniel Brett, Eleanor-Rose Farley, Triona Casey, Nicola Dalrymple, Katherine De Wilde, Katie Fletcher, Jennifer Harper, Verena Hinze, Nils Kapplemann, Maria Kempnich, Konstantina Komnindou, Suzannah Laws, Liz Lord, Emma Medlicott, Lucy Palmer, Ariane Petit, Alice Phillips, Isobel Pryor-Nitsch, Lucy Radley, Anam Raja, Elsie Sellars, Jem Shackleford, Anna Sonley, Laura Taylor, Alice Tickell, Lucy Warriner, Sarah Byford, Mark Greenberg, Tamsin Ford, Susan Gathercole, Russell Viner, Phil Zelazo, Rachel Knight, Blanca Piera Pi-Sunyer, Kirsten Thomas, Susan Ball, Poushali Ganguli Ben Jones, Nick Allen, Susan Bogels, Pim Cuijpers, Celene Domitrovich, Uta Frith, Terrie Moffitt, and Vikram Patel

Data availability statement

Data are available upon reasonable request. The data and codebook for the MYRIAD Trial are available from the corresponding author upon request (release of data is subject to an approved proposal and a signed data access agreement).

Ethics statements

Patient consent for publication

Not applicable.

Ethics approval

This study involves human participants and was approved by University of Cambridge psychology research ethics committee (Reference: PRE.2015.067) and UCL psychology research ethics committee (Reference: 7199001). Participants gave informed consent to participate in the study before taking part.

References

  • 1. Creswell JD. Mindfulness interventions. Annu Rev Psychol 2017;68:491–516. 10.1146/annurev-psych-042716-051139 [DOI] [PubMed] [Google Scholar]
  • 2. Piet J, Hougaard E. The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis. Clin Psychol Rev 2011;31:1032–40. 10.1016/j.cpr.2011.05.002 [DOI] [PubMed] [Google Scholar]
  • 3. Dunning DL, Griffiths K, Kuyken W, et al. Research review: The effects of mindfulness-based interventions on cognition and mental health in children and adolescents - a meta-analysis of randomized controlled trials. J Child Psychol Psychiatry 2019;60:244–58. 10.1111/jcpp.12980 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Hölzel BK, Lazar SW, Gard T, et al. How does mindfulness meditation work? Proposing mechanisms of action from a conceptual and neural perspective. Perspect Psychol Sci 2011;6:537–59. 10.1177/1745691611419671 [DOI] [PubMed] [Google Scholar]
  • 5. Lutz A, Slagter HA, Dunne JD, et al. Attention regulation and monitoring in meditation. Trends Cogn Sci 2008;12:163–9. 10.1016/j.tics.2008.01.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Schweizer S, Grahn J, Hampshire A, et al. Training the emotional brain: improving affective control through emotional working memory training. J Neurosci 2013;33:5301–11. 10.1523/JNEUROSCI.2593-12.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Schweizer S, Hampshire A, Dalgleish T. Extending brain-training to the affective domain: increasing cognitive and affective executive control through emotional working memory training. PLoS One 2011;6:e24372. 10.1371/journal.pone.0024372 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Schweizer S, Gotlib IH, Blakemore S-J. The role of affective control in emotion regulation during adolescence. Emotion 2020;20:80. 10.1037/emo0000695 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Brigman G, Campbell C. Helping students improve academic achievement and school success behavior. Professional School Counseling 2003;1:91–8 https://www.jstor.org/stable/42732548 [Google Scholar]
  • 10. Kraemer HC, Wilson GT, Fairburn CG, et al. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 2002;59:877–83. 10.1001/archpsyc.59.10.877 [DOI] [PubMed] [Google Scholar]
  • 11. Galante J, Dufour G, Vainre M, et al. A mindfulness-based intervention to increase resilience to stress in university students (the mindful student study): a pragmatic randomised controlled trial. Lancet Public Health 2018;3:e72–81. 10.1016/S2468-2667(17)30231-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Ford T, John A, Gunnell D. Mental health of children and young people during pandemic. BMJ 2021;10:n614. 10.1136/bmj.n614 [DOI] [PubMed] [Google Scholar]
  • 13. Dalgleish T, Blakemore S-J, Dunning DL. The impact of mindfulness training in adolescence on socio-cognitive-affective processes and on mental health before and after COVID-19: a trial protocol and analysis plan; 2020.
  • 14. Mindfulness in schools project . B curriculum. Available: https://mindfulnessinschools.org/teach-dot-b/dot-b-curriculum/ [Accessed 23 Jan 2022].
  • 15. Kuyken W, Weare K, Ukoumunne OC, et al. Effectiveness of the mindfulness in schools programme: non-randomised controlled feasibility study. Br J Psychiatry 2013;203:126–31. 10.1192/bjp.bp.113.126649 [DOI] [PubMed] [Google Scholar]
  • 16. Preston SD, Stansfield RB. I know how you feel: task-irrelevant facial expressions are spontaneously processed at a semantic level. Cogn Affect Behav Neurosci 2008;8:54–64. 10.3758/cabn.8.1.54 [DOI] [PubMed] [Google Scholar]
  • 17. Robertson IH, Manly T, Andrade J, et al. Oops performance correlates of everyday attentional failures in traumatic brain injured and normal subjects. Neuropsychologia 1997;35:747–58. 10.1016/s0028-3932(97)00015-8 [DOI] [PubMed] [Google Scholar]
  • 18. Gioia GA, Isquith PK, Guy SC. Behavior rating inventory of executive Function®. Second Ed. Lutz, FL: PAR Inc, 2015. [Google Scholar]
  • 19. Greco LA, Baer RA, Smith GT. Assessing mindfulness in children and adolescents: development and validation of the child and adolescent mindfulness measure (CAMM). Psychol Assess 2011;23:606. 10.1037/a0022819 [DOI] [PubMed] [Google Scholar]
  • 20. Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale. J Psychopathol Behav Assess 2004;26:41–54. 10.1023/B:JOBA.0000007455.08539.94 [DOI] [Google Scholar]
  • 21. Kuyken W, Ball S, Crane C. Effectiveness and cost-effectiveness of a universal school-based mindfulness training programme compared with normal school provision in reducing risk of mental health problems and promoting well-being in adolescence: results of the myriad cluster randomised controlled trial; 2021. 10.1186/s13063-017-1917-4 [DOI] [PMC free article] [PubMed]
  • 22. Radloff LS. The use of the center for epidemiologic studies depression scale in adolescents and young adults. J Youth Adolesc 1991;20:149–66. 10.1007/BF01537606 [DOI] [PubMed] [Google Scholar]
  • 23. Goodman R. The strengths and difficulties questionnaire: a research note. J Child Psychol Psychiatry 1997;38:581–6. 10.1111/j.1469-7610.1997.tb01545.x [DOI] [PubMed] [Google Scholar]
  • 24. Tennant R, Hiller L, Fishwick R, et al. The Warwick-Edinburgh mental well-being scale (WEMWBS): development and UK validation. Health Qual Life Outcomes 2007;5:1–3. 10.1186/1477-7525-5-63 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Chorpita BF, Yim L, Moffitt C, et al. Assessment of symptoms of DSM-IV anxiety and depression in children: a revised child anxiety and depression scale. Behav Res Ther 2000;38:835–55. 10.1016/s0005-7967(99)00130-8 [DOI] [PubMed] [Google Scholar]
  • 26. Nolen-Hoeksema S. The role of rumination in depressive disorders and mixed anxiety/depressive symptoms. J Abnorm Psychol 2000;109:504–11. 10.1037/0021-843X.109.3.504 [DOI] [PubMed] [Google Scholar]
  • 27. Grund S, Lüdtke O, Robitzsch A. Multiple imputation of multilevel missing data: an introduction to the R package pan. Sage Open 2016;6:2158244016668220. 10.1177/2158244016668220 [DOI] [Google Scholar]
  • 28. Montero-Marin J, Allwood M, Ball S, et al. School-based mindfulness training in early adolescence: what works, for whom and how in the MYRIAD trial? Evid Based Ment Health 2022;25:117–24. 10.1136/ebmental-2022-300439 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Cattell RB. Theory of fluid and crystallized intelligence: a critical experiment. J Educ Psychol 1963;54:1. 10.1037/h0046743 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary data

ebmental-2022-300460supp001.pdf (499.8KB, pdf)

Data Availability Statement

Data are available upon reasonable request. The data and codebook for the MYRIAD Trial are available from the corresponding author upon request (release of data is subject to an approved proposal and a signed data access agreement).


Articles from Evidence-Based Mental Health are provided here courtesy of BMJ Publishing Group

RESOURCES